Sugi Predict

Sugi Predict / Targets / LRRFIP1

LRRFIP1

Leucine-rich repeat flightless-interacting protein 1 · Q32MZ4 · LRRFIP1 on Sugi Atlas →

0 patent compounds predicted against LRRFIP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LRRFIP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa PHASE1COMPLETED
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease. PHASE1COMPLETED
The Effects of GLA on Human Volunteers PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Defining an Obesity QTL on Chromosome 3q nanCOMPLETED
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Rostock International Parkinson's Disease Study (ROPAD) nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations nanUNKNOWN
Genetic Basis of Abdominal Aortic Aneurysm nanCOMPLETED
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) nanCOMPLETED
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Genetics of Familial and Sporadic ALS nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Genetic Predictors of Lithium Response in Bipolar Disorder nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases nanCOMPLETED
A Family Study of Copy Number Variations in Patients With Autism Spectrum Disorder nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LRRFIP1 binder may also engage these)

ProteinNameSimilarity
Q66HF9 — 0.996 Q66HF9 →
Q3UZ39 — 0.996 Q3UZ39 →
O75410 — 0.986 O75410 →
Q4KLH6 — 0.985 Q4KLH6 →
Q7Z5L2 — 0.984 Q7Z5L2 →
Q6ZQ06 — 0.984 Q6ZQ06 →
Q91365 — 0.984 Q91365 →
Q6Y685 — 0.983 Q6Y685 →
Q5R6D6 — 0.983 Q5R6D6 →
Q9Y6A5 — 0.983 Q9Y6A5 →
A6H8Y1 — 0.982 A6H8Y1 →
Q9WTQ5 — 0.982 Q9WTQ5 →
P86839 — 0.982 P86839 →
P27123 — 0.982 P27123 →
Q8CDM4 — 0.981 Q8CDM4 →
Q571C7 — 0.981 Q571C7 →
P56716 — 0.981 P56716 →
Q3UMF0 — 0.981 Q3UMF0 →
Q5TB80 — 0.981 Q5TB80 →
Q5RHP9 — 0.981 Q5RHP9 →
Q96T21 — 0.980 Q96T21 →
Q9ULD2 — 0.980 Q9ULD2 →
Q6GNV6 — 0.980 Q6GNV6 →
Q62394 — 0.980 Q62394 →
Q9WUF3 — 0.980 Q9WUF3 →
A0JM80 — 0.980 A0JM80 →
Q69ZL1 — 0.979 Q69ZL1 →
Q8C9B9 — 0.979 Q8C9B9 →
Q05A80 — 0.979 Q05A80 →
Q5EBJ4 — 0.979 Q5EBJ4 →